# Fitlife Brands, Inc.: Form 10-Q for the period ended Jun 30, 2018

- Company: [Fitlife Brands, Inc.](/companies/ftlf.md) (CIK 1374328)
- Form: 10-Q
- Filed: 2018-08-14
- Accepted by EDGAR: Aug 14, 2018, 09:02 ET
- Period: 2018-06-30
- Accession: 0001654954-18-009013
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1374328/000165495418009013/ftlf10q_jun302018.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374328/000165495418009013/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2018-04-01 to 2018-06-30 | $4.4m | us-gaap:Revenues |
| Revenue | 6 months, 2018-01-01 to 2018-06-30 | $9.0m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2018-04-01 to 2018-06-30 | $2.6m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months, 2018-01-01 to 2018-06-30 | $5.3m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2018-04-01 to 2018-06-30 | $1.8m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2018-01-01 to 2018-06-30 | $3.7m | us-gaap:GrossProfit |
| Operating income | 3 months, 2018-04-01 to 2018-06-30 | $214.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2018-01-01 to 2018-06-30 | $452.0k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2018-04-01 to 2018-06-30 | $44.0k | us-gaap:InterestExpense |
| Interest expense | 6 months, 2018-01-01 to 2018-06-30 | $65.0k | us-gaap:InterestExpense |
| Net income | 3 months, 2018-04-01 to 2018-06-30 | $170.0k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2018-01-01 to 2018-06-30 | $388.0k | us-gaap:NetIncomeLoss |
| Operating cash flow | 6 months, 2018-01-01 to 2018-06-30 | $882.0k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2018-06-30 | $940.0k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-06-30 | $5.6m | us-gaap:AssetsCurrent |
| Total assets | at 2018-06-30 | $6.1m | us-gaap:Assets |
| Current liabilities | at 2018-06-30 | $4.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2018-06-30 | $4.7m | us-gaap:Liabilities |
| Current portion of debt | at 2018-06-30 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2018-06-30 | $1.4m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 23,646 characters.

*The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes appearing elsewhere in this report. This discussion and analysis may contain forward-looking statements based on assumptions about our future business.*

### Overview

FitLife Brands, Inc. (the “*Company”*) is a national provider of innovative and proprietary nutritional supplements for health-conscious consumers marketed under the brand names NDS Nutrition Products™ (www.ndsnutrition.com), PMD™ (www.pmdsports.com), SirenLabs™ (www.sirenlabs.com), CoreActive™ (www.coreactivenutrition.com), and Metis Nutrition™ (www.metisnutrition.com) (together, “*NDS Products”*). With the consummation of the merger with iSatori, Inc. (“*iSatori”*) on September 30, 2015, which became effective on October 1, 2015, described below (the “*Merger”*), the Company added several brands to its product portfolio, including iSatori (www.isatori.com), BioGenetic Laboratories, and Energize (together, “*iSatori Products”).* The NDS Products are distributed principally through franchised General Nutrition Centers, Inc. (“*GNC”*) stores located both domestically and internationally, and, with the addition of Metis Nutrition, through corporate GNC stores in the United States. The iSatori Products are sold through more than 25,000 retail locations, which include specialty, mass, and online.

The Company was incorporated in the State of Nevada on July 26, 2005. In October 2008, the Company acquired the assets of NDS Nutritional Products, Inc., a Nebraska corporation, and moved those assets into its wholly owned subsidiary NDS Nutrition Products, Inc., a Florida corporation (“*NDS”*). The Company’s NDS Products are sold through NDS and the iSatori Products are sold through iSatori, Inc., a Delaware corporation and a wholly owned subsidiary of the Company.

FitLife Brands is headquartered in Omaha, Nebraska. For more information on the Company, please go to http://www.fitlifebrands.com. The Company’s common stock currently trades under the symbol “FTLF” on the OTC:PINK market.

### Results of Operations

### Comparison of Three and Six Months Ended June 30, 2018 to the Three and Six Months Ended June 30, 2017

*Net Sales.* Revenue for the three months ended June 30, 2018 decreased 12.8% to $4,379,000 as compared to $5,022,000 for the three months ended June 30, 2017. Revenue for the six months ended June 30, 2018 decreased 15.3% to $8,993,000 as compared to $10,612,000 for the six months ended June 30, 2017. Revenue for the three- and six-month periods ended June 30, 2018 compared to the prior three and six-month periods, in part, reflects declining traffic trends and lower unit sales at retail leading to lower same store sales in GNC, our principal distribution channel, as well as certain inventory level adjustments by GNC resulting from such trends. While no assurances can be given, management believes the negative trends affecting GNC and the overall retail segment have stabilized. Moreover, declining sales at retail during the three and six months ended June 30, 2018 were partially offset by a substantial increase in online sales. As a result of the macro issues affecting retail generally, management is focused on developing its omnichannel product sales capability through its retail partners and online through ecommerce platforms to drive additional incremental sales. While sales derived from such channels were not material as a percentage of total sales during the three and six month periods ended June 30, 2018, management believes the its online channels will provide significant incremental growth opportunities in the long-term.

*Cost of Goods Sold.* Cost of goods sold for the three months ended June 30, 2018 decreased to $2,573,000 as compared to $3,499,000 for the three months ended June 30, 2017. The decrease during the three-month period is principally attributable to lower total sales volumes. Cost of goods sold for the six months ended June 30, 2018 decreased to $5,271,000 as compared to $7,168,000 for the six months ended June 30, 2017. The decrease during the six-month period is principally attributable to lower sales in the period.

*Gross Profit Margin.* Gross profit for the three months ended June 30 2018 increased to $1,806,000 as compared to $1,523,000 for the three months ended June 30, 2017. Gross profit for the six months ended June 30, 2018 increased to $3,722,000 as compared to $3,444,000 for the six months ended June 30, 2017. The increase during the three and six month period is principally attributable to reduced returns and vendor funded discounts.

Gross margin for the three and six months ended June 30, 2018 increased to 41.2% and 41.4% from 30.3% and 32.5% for the comparable three and six month periods last year. The increase in gross margin was primarily attributable to materially lower vendor funded discounts and reduced write-off activity.

*General and Administrative Expense.* General and administrative expense for the three months ended June 30, 2018 decreased to $856,000 as compared to $1,010,000 for the three months ended June 30, 2017. The decrease in general and administrative expense for the three months ended June 30, 2018 is principally attributable to ongoing cost reduction initiatives, subletting certain facilities and lower headcount. General and administrative expense for the six months ended June 30, 2018 decreased to $1,709,000 as compared to $2,170,000 for the six months ended June 30, 2017. The decrease in general and administrative expense for the six months ended June 30, 2018 is similarly attributable to ongoing cost reduction initiatives.

*Selling and Marketing Expense.* Selling and marketing expense for the three months ended June 30, 2018 decreased to $718,000 as compared to $913,000 for the three months ended June 30, 2017. Selling and marketing expense for the six months ended June 30, 2018 decreased to $1,523,000 as compared to $1,861,000 for the six months ended June 30, 2017. The decrease in selling and marketing expense for the three and six and month periods ended June 30, 2018 is principally the result of budgetary controls.

*Depreciation and Amortization.* Depreciation and amortization for the three months ended June 30, 2018 decreased to $18,000 as compared to $117,000 for the three months ended June 30, 2017. Depreciation and amortization for the six months ended June 30, 2018 decreased to $38,000 as compared to $237,000 for the six months ended June 30, 2017. The decrease in both periods was primarily attributable to decrease in amortization expense due to the write-off of certain intangible assets during the fourth quarter of 2017.

*Net Income/(Loss).* We generated a net income of $170,000 for the three-month period ended June 30, 2018 as compared to a net loss of $(551,000) for the three months ended June 30, 2017. We generated a net income of $388,000 for the six-month period ended June 30, 2018 as compared to a net loss of $(884,000) for the six months ended June 30, 2017. The change from a net loss to net income for the three- and six-month periods ended June 30, 2018 compared to the comparable period last year is principally attributable to stronger margins and reduced operating expense, which offset lower sales volumes.

### Liquidity and Capital Resources

At June 30, 2018, we had positive working capital of approximately $913,000, compared to $369,000 at December 31, 2017. Our principal sources of liquidity at June 30, 2018 consisted of $940,000 of cash and $1,848,000 from accounts receivable. The increase in working capital is principally attributable to the payment of the line of credit and term loan, both of which were current liabilities at December 31, 2017.

The Company has historically financed its operations primarily through cash flow from operations and equity and debt financings, and more recently, the factoring of accounts receivable. The Company has also provided for its cash needs by issuing common stock, options and warrants for certain operating costs, including consulting and professional fees. The Company currently anticipates that cash derived from operations and existing cash resources will be sufficient to provide for the Company’s liquidity for the next 12 months.

In December 2017, the Company, through its Subsidiaries, entered into the Merchant Agreement with Compass. Under the terms of the Merchant Agreement, subject to the satisfaction of certain conditions to funding, the Subsidiaries agreed to sell to Compass, and Compass agreed to purchase from the Subsidiaries, certain accounts owing from customers of such Subsidiaries, including GNC. On January 22, 2018, the Subsidiaries sold to Compass accounts receivable under the Merchant Agreement aggregating approximately $2.0 million, the proceeds from which were used to pay U.S. Bank, inclusive of a payment of approximately $360,000 from the Company, all principal and accrued interest due and owed U.S. Bank under the terms of the Notes and revolving line of credit.

The Company is dependent on cash flow from operations and the accumulation of additional receivables available to sell to Compass under the terms of the Merchant Agreement to satisfy its working capital requirements. No assurances can be given that cash flow from operations and/or that the Company will have access to additional capital under the terms of the Merchant Agreement necessary to provide for the Company’s liquidity for the next twelve months. Should the Company be unable to generate sufficient revenue in the future to achieve positive cash flow from operations, and/or should capital be unavailable under the terms of the Merchant Agreement, additional working capital will be required. Management at present has no intention to raise additional working capital through the sale of equity or debt securities and believes the agreement with Compass will provide sufficient capital necessary to operate the business over the next twelve months. In the event the Company fails to achieve positive cash flow from operations, additional capital is unavailable under the terms of the Merchant Agreement, and management is otherwise unable to secure additional working capital through the issuance of equity or debt securities, the Company’s business would be materially and adversely harmed.

During the six month period ended June 30, 2018, the Company sold to the factor, on a recourse basis, an aggregate of $8,152,000 of invoices, net of credit memos, for cash proceeds of $7,784,000. In addition, the Company also incurred fees and other charges in the aggregate of $61,000 which was reflected as part of interest expense in the accompanying statement of operations. As of June 30, 2018, total due from Factor amounted to $307,000 which represents the 20% holdback for invoices it had not yet collected.

*Cash Provided by Operations.* Our cash provided by operating activities for the six months ended June 30, 2018 was $882,000, as compared to $424,000 for the six months ended June 30, 2017. The increase is principally attributable to variations in certain working capital accounts resulting from our agreement with Compass. Net working capital decreased to $913,000 as of the quarter ended June 30, 2018 compared to $2,612,000 as of June 30, 2017.

*Cash Provided by (Used in) Investing Activities.* Cash provided by investing activities for the six months ended June 30, 2018 was $2,000 as compared to $(10,000) used in investing activities for the six months ended June 30, 2017.

*Cash Used in Financing Activities.* Our cash used in financing activities for the six months ended June 30, 2018 was $(1,206,000) as compared to cash used in financing activities of $(276,000) during the six months ended June 30, 2017. The primary difference was the payoff of all amounts owed to U.S. Bank under both the line of credit and term loan during the six months ended June 30, 2018 plus the impact of the factoring arrangement with Compass.

### Critical Accounting Policies and Estimates

Our discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, expense, and related disclosure of contingent assets and liabilities. We evaluate, on an on-going basis, our estimates and judgments, including those related to the useful life of the assets. We base our estimates on historical experience and assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

The methods, estimates and judgments we use in applying our most critical accounting policies have a significant impact on the results that we report in our consolidated financial statements. The SEC considers an entity’s most critical accounting policies to be those policies that are both most important to the portrayal of a company’s financial condition and results of operations and those that require management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about matters that are inherently uncertain at the time of estimation. For a more detailed discussion of the accounting policies of the Company, see Note 3 of the Notes to the Condensed Consolidated Financial Statements, “*Summary of Significant Accounting Policies.”*

We believe the following critical accounting policies, among others, require significant judgments and estimates used in the preparation of our consolidated financial statements.

#### Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“*GAAP”*) requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the financial statements are published, and (iii) the reported amount of net sales and expense recognized during the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of financial statements; accordingly, actual results could differ from these estimates.

These estimates and assumptions also affect the reported amounts of accounts receivable, inventories, goodwill, revenue, costs and expense and valuations of long term assets, allowance for deferred tax assets and equity instruments issued for services during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.

#### Goodwill

The Company had goodwill with a carrying value of $225,000 as of June 30, 2018 and December 31, 2017, respectively, as a result of the acquisition of NDS in October 2008. The Company adopted ASC Topic 350 – *Goodwill and Other Intangible Assets*. In accordance with ASC Topic 350, goodwill, which represents the excess of purchase price and related costs over the value assigned to net tangible and identifiable intangible assets of businesses acquired and accounted for under the purchase method, acquired in business combinations is assigned to reporting units that are expected to benefit from the synergies of the combination as of the acquisition date. Under this standard, goodwill and intangibles with indefinite useful lives are no longer amortized. The Company assesses goodwill and indefinite-lived intangible assets for impairment annually during the fourth quarter, or more frequently if events and circumstances indicate impairment may have occurred in accordance with ASC Topic 350. If the carrying value of a reporting unit’s goodwill exceeds its implied fair value, the Company records an impairment loss equal to the difference. ASC Topic 350 also requires that the fair value of indefinite-lived purchased intangible assets be estimated and compared to the carrying value. The Company recognizes an impairment loss when the estimated fair value of the indefinite-lived purchased intangible assets is less than the carrying value.

Identifiable intangible assets are stated at cost and accounted for based on whether the useful life of the asset is finite or indefinite. Identified intangible assets with finite useful lives are amortized using the straight-line methods over their estimated useful lives, which was originally ten years. Intangible assets with indefinite lives are not amortized to operations, but instead are reviewed for impairment at least annually, or more frequently if there is an indicator of impairment.

As of June 30, 2018 and December 31, 2017, there were no indicators of impairment for the recorded goodwill of $225,000, respectively.

#### Share Based Payment

The Company issues stock options, warrants and common stock as share-based compensation to employees and non-employees. The Company accounts for its share-based compensation to employees in accordance with FASB ASC718 “*Compensation - Stock Compensation.”* Stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award, and is recognized as expense over the requisite service period.

The Company accounts for share-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505-50 “*Equity - Based Payment to Non-Employees.”* Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received, or (b) the equity instruments issued. The final fair value of the share-based payment transaction is determined at the performance completion date. For interim periods, the fair value is estimated and the percentage of completion is applied to that estimate to determine the cumulative expense recorded.

The Company values stock compensation based on the market price on the measurement date. For employees this is the date of grant, and for non-employees, this is the date of performance completion. The Company values stock options and warrants using the Black-Scholes option pricing model.

#### Revenue Recognition

The Company’s revenue is comprised of sales of nutritional supplements to consumers, primarily through GNC stores.

In September 2014, the Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09 (ASU No. 2014-09) regarding revenue recognition. The new standard provides authoritative guidance clarifying the principles for recognizing revenue and developing a common revenue standard for U.S. generally accepted accounting principles. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods to customers in an amount that reflects the consideration to which the entity expects to be entitled in the exchange for those goods or services. The ASU became effective January 1, 2018.

Due to the nature of the products sold by the Company, the adoption of the new standard has had no quantitative effect on the financial statements. However, the guidance requires additional disclosures to help users of financial statements better understand the nature, amount, timing, and uncertainty of revenue that is recognized.

The Company previously recognized revenue when risk of loss transferred to our customers and collection of the receivable was reasonably assured, which generally occurs when the product is shipped. A product is not shipped without an order from the customer and credit acceptance procedures performed. The Company allows for returns within 30 days of purchase from end-users. GNC may return purchased products to the Company under certain circumstances, which include expired or soon to be expired products located in GNC corporate stores or at any of its distribution centers, and products that are subject to a recall or that contain an ingredient or ingredients that are subject to a recall by the FDA.

Under the new guidance, revenue is recognized when control of promised goods is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods. The Company reviews its sales transactions to identify contractual rights, performance obligations, and transaction prices, including the allocation of prices to separate performance obligations, if applicable. Revenue and costs of sales are recognized once products are delivered to the customer’s control and performance obligations are satisfied.

All products sold by the Company are distinct individual products and consist of nutritional supplements and related supplies. The products are offered for sale solely as finished goods, and there are no performance obligations required post-shipment for customers to derive the expected value from them. Other than promotional activities, which can vary from time to time but nevertheless are entirely within the Company’s control, contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time.

Control of products we sell transfers to customers upon shipment from our facilities, and the Company’s performance obligations are satisfied at that time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfillment activity rather than promised goods to the customer. Payment for sales are generally made by check, credit card, or wire transfer. Historically the Company has not experienced any significant payment delays from customers.

We provide a 30-day right of return for our products. A right of return does not represent a separate performance obligation, but because customers are allowed to return products, the consideration to which the Company expects to be entitled is variable. Upon evaluation of returns, the Company determined that substantially less than 5% of products are returned, and therefore believes it is probable that such returns will not cause a significant reversal of revenue in the future. We assess our contracts and the reasonableness of our conclusions on a quarterly basis.

### Recent Accounting Pronouncements

See Note 3 in the accompanying financial statements for a discussion of recent accounting pronouncements.

### WHERE YOU CAN FIND MORE INFORMATION

You are advised to read this Quarterly Report on Form 10-Q in conjunction with other reports and documents that we file from time to time with the SEC. In particular, please read our Quarterly Reports on Form 10-Q, Annual Report on Form 10-K, and Current Reports on Form 8-K that we file from time to time. You may obtain copies of these reports directly from us or from the SEC at the SEC’s Public Reference Room at 100 F. Street, N.E. Washington, D.C. 20549, and you may obtain information about obtaining access to the Reference Room by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains information for electronic filers at its website http://www.sec.gov.

## Market risk

As filed, 1,411 characters.

Our business is currently conducted principally in the United States. As a result, our financial results are not affected by factors such as changes in foreign currency exchange rates or economic conditions in foreign markets. We do not engage in hedging transactions to reduce our exposure to changes in currency exchange rates, although as the geographical scope of our business broadens, we may do so in the future.

Our exposure to risk for changes in interest rates relates primarily to our investments in short-term financial instruments. Investments in both fixed rate and floating rate interest earning instruments carry some interest rate risk. The fair value of fixed rate securities may fall due to a rise in interest rates, while floating rate securities may produce less income than expected if interest rates fall. Partly as a result of this, our future interest income may fall short of expectations due to changes in interest rates or we may suffer losses in principal if we are forced to sell securities that have fallen in estimated fair value due to changes in interest rates. However, as substantially all of our cash equivalents consist of bank deposits and short-term money market instruments, we do not expect any material change with respect to our net income as a result of an interest rate change.

We do not hold any derivative instruments and do not engage in any hedging activities.

## Controls and procedures

As filed, 3,995 characters.

(a) *Evaluation of Disclosure Controls and Procedures*

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures were designed to provide reasonable assurance that the controls and procedures would meet their objectives. As required by SEC Rule 13a-15(b), our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level.

Our Chief Executive Officer and Chief Financial Officer are responsible for establishing and maintaining adequate internal control over our financial reporting. In order to evaluate the effectiveness of internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act, management has conducted an assessment, including testing, using the criteria in Internal Control — Integrated Framework, issued by the Committee of Sponsoring Organizations of the Treadway Commission (“*COSO”*). Our system of internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Management has used the framework set forth in the report entitled Internal Control-Integrated Framework published by the COSO to evaluate the effectiveness of our internal control over financial reporting. Based on this assessment, our Chief Executive Officer and Chief Financial Officer have concluded that our internal control over financial reporting was effective as of June 30, 2018. This Quarterly Report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Our internal control over financial reporting was not subject to attestation by our independent registered public accounting firm pursuant to temporary rules of the SEC that permit us to provide only management’s report in this Quarterly Report. There has been no change in our internal controls over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

(b) *Changes in Internal Controls Over Financial Reporting*

There have been no changes in our internal controls over financial reporting or in other factors that could materially affect, or are reasonably likely to affect, our internal controls over financial reporting during the quarter ended June 30, 2018. There have not been any significant changes in the Company’s critical accounting policies identified since the Company filed its Annual Report on Form 10-K for the year ended December 31, 2017.

### PART II

### OTHER INFORMATION

## Risk factors

As filed, 697 characters.

Our results of operations and financial condition are subject to numerous risks and uncertainties described in our Annual Report on Form 10-K for our fiscal year ended December 31, 2017, filed on April 17, 2018. You should carefully consider these risk factors in conjunction with the other information contained in this Quarterly Report. Should any of these risks materialize, our business, financial condition and future prospects could be negatively impacted. As of June 30, 2018, there are no risk factors identified by the Company in addition to the risk factors previously disclosed in Part I, Item 1A, “*Risk Factors”* in our Annual Report on Form 10-K for the year ended December 31, 2017.

Filed Aug 14, 2018.
Source: SEC EDGAR, the filing index for accession 0001654954-18-009013. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.
